The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles
Derived from pooled blood donations, polyvalent immunoglobulins are used for post-exposure prophylaxis as one aspect of the public health management of hepatitis A, rubella and measles. This review summarizes the safety profile of these blood products and the current recommendations for their use fo...
Saved in:
Main Author: | Megan K. Young (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of Measles and Rubella Immunoglobulin G Titers in COVID-19 Patients
by: Başbulut E, et al.
Published: (2024) -
Rubella antibodies in Australian immunoglobulin products
by: Megan K. Young, et al.
Published: (2017) -
Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures
by: Ravish S. Haradanhalli, et al.
Published: (2022) -
Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000) -
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy
by: Mohamad Mroué, et al.
Published: (2024)